Prolia and Multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Multiple sclerosis is reported as a side effect among people who take Prolia (denosumab), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Ampyra, and have Gait disturbance.
The phase IV clinical study analyzes which people have Multiple sclerosis when taking Prolia. It is created by eHealthMe based on reports of 150,727 people who have side effects when taking Prolia from the FDA, and is updated regularly.
What is Prolia?
Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,089 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
150,727 people reported to have side effects when taking Prolia.
Among them, 107 people (0.07%) have Multiple sclerosis.
Among these 107 people:
How long have people been on Prolia when they have Multiple sclerosis? *
What is the gender of people who have Multiple sclerosis when taking Prolia? *
What is the age of people who have Multiple sclerosis when taking Prolia? *
What are other drugs people take besides Prolia? *
What are other side effects people have besides Multiple sclerosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Prolia and have Multiple sclerosis?
- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Prolia:
- Prolia (151,388 reports)
Multiple sclerosis treatments and more:
- Multiple sclerosis (799,636 reports)
How severe was Multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of denosumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Prolia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,089 drugs)
Browse all the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,358 conditions)
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on denosumab (the active ingredients of Prolia) and Prolia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Propofol cause Flank Pain? - 3 seconds ago
- Could Propofol cause Anticonvulsant Drug Level Increased? - 4 seconds ago
- Could Profen cause Calcium Deficiency? - 6 seconds ago
- Could Hectorol cause Fever? - 14 seconds ago
- Drug interactions of Alprostadil and Cialis - 18 seconds ago
- Could Viadur cause Muscle Aches? - 21 seconds ago
- Could Marijuana cause Red Blood Cell Count Decreased? - 24 seconds ago
- Could Promethazine cause Dizziness Aggravated? - 35 seconds ago
- Drug interactions of Repatha and Alphagan - 43 seconds ago
- Drug interactions of Daytrana and Provera - 45 seconds ago